Business Context and Reporting Period
This Form 6-K filing by Psyence Biomedical Ltd. covers the month of January 2026, with a report date of January 27, 2026. The filing serves as a current report regarding corporate governance events rather than a periodic financial statement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the status of a shareholder meeting and contains no financial performance data.
Material Changes
The primary material event reported is the adjournment of the Company's annual and special meeting of shareholders. Originally scheduled for January 22, 2026, the meeting was postponed due to the absence of a quorum. The meeting has been rescheduled for February 12, 2026.
Outlook, Risks, and Management Commentary
- Meeting Reschedule: The new meeting date is February 12, 2026, at 9:00 a.m. New York Time / 4:00 p.m. Cape Town time.
- Location: The meeting will be held at Venture Workspace Riverlands, Office Building 4, Riverlands, 51 Gogosoa Street, Observatory, Cape Town, 7935, South Africa.
- Record Date: The record date for determining voting eligibility remains December 23, 2025.
- Exhibits: A press release detailing the adjournment is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the new meeting date of February 12, 2026, and confirm attendance logistics for the Cape Town location.
- Confirm shareholder eligibility based on the unchanged record date of December 23, 2025.
- Review the attached press release (Exhibit 99.1) for any additional details regarding the agenda or voting procedures for the rescheduled meeting.